Compensation Mechanisms in Parkinson's Disease
Trial
N/A
Completed
Feb. 17, 2022
Assessment of Fluctuating Parkinson's Disease With Sensor-based Home Monitoring
Trial
N/A
Completed
Feb. 17, 2022
Systematic Follow up of Second Line Treatments for Parkinson's Disease (Deep Brain Stimulation, Apomorphin Pump, Duodopa Pump)
Trial
N/A
Not yet recruiting
Feb. 16, 2022
Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.
Trial
Phase 3
Terminated
Feb. 15, 2022
Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID
Trial
Phase 3
Terminated
Feb. 15, 2022
Incentive Spirometer and Inspiratory Muscle Trainer
Trial
N/A
Completed
Feb. 9, 2022
Spine MRI in Patients With Deep Brain Stimulation (DBS)
Trial
N/A
Completed
Feb. 8, 2022
DTI in Evaluation of Parkinsons Disease
Trial
N/A
Unknown
Feb. 8, 2022
Utilization of Target Ranges to Treat Parkinson's Disease With the PKG
Trial
N/A
Terminated
Feb. 7, 2022
Multi-limb Dual-task Control in Parkinson's Disease
Trial
N/A
Completed
Feb. 6, 2022
Adaptive Closed Loop Neuromodulation and Neural Signatures of Parkinson's Disease
Trial
N/A
Completed
Jan. 31, 2022
Movement Disorders and Early Maladaptive Schemas
Trial
N/A
Completed
Jan. 30, 2022
Effect of Immersive Virtual Reality Exergames in Patients With Parkinson's Disease
Trial
N/A
Completed
Jan. 27, 2022
Impact of Swallowing Impairment on Individuals With Parkinson Disease
Trial
N/A
Completed
Jan. 26, 2022
Treatment Protocol for PD Fatigue Management With CBT
Trial
N/A
Completed
Jan. 26, 2022
Study of Motor Inhibition in Parkinson's Disease and Focal Hand Dystonia
Trial
N/A
Unknown
Jan. 25, 2022
Parkinson's KinetiGraph as Tool for DBS Eligibility Assessment
Trial
N/A
Completed
Jan. 25, 2022
Self-Management Behaviors of Arabs and Jews With Parkinson's Disease and Their Associations With Health Outcomes
Trial
N/A
Unknown
Jan. 25, 2022
Benefits of Mild Body Exercises in Parkinson's Disease
Trial
N/A
Unknown
Jan. 20, 2022
ExAblate Transcranial MRgFUS of the Globus Pallidum for Treatment of Parkinson's Disease
Trial
N/A
Completed
Jan. 18, 2022